Safety, Tolerability and Pharmacokinetics Trial of JDP-205 Injection 10 mg
Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
This study is to investigate the pharmacokinetics (PK) together with the safety and
tolerability of JDP-205 at 5 mg and 10 mg intravenous doses and 10 mg intramuscular dose, in
comparison to the marketed cetirizine oral product Zyrtec® 10 mg tablets (an OTC product) in
healthy male and female volunteers after a single dose administration.